Indirect Coombs
Private Indirect Coombs blood test in London for £109, detecting circulating red-cell antibodies with results expected in around 3–4 days.
Turnaround time
3-4 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Indirect Coombs Test
The Indirect Coombs test, also called the Indirect Antiglobulin Test or IAT, detects antibodies circulating in serum that may react against red blood-cell antigens.
The test contains 1 biomarker: Indirect Coombs Test.
This differs fundamentally from the Direct Coombs or Direct Antiglobulin Test.
The Direct Coombs test detects antibodies or complement already attached to a person's red blood cells.
The Indirect Coombs test instead detects free antibodies circulating in the serum that have the potential to bind to red blood cells carrying the relevant antigen.
This distinction makes the Indirect Coombs test particularly important in pregnancy and transfusion medicine.
During pregnancy, maternal red-cell antibodies can sometimes cross the placenta and react against fetal red blood cells.
Antenatal antibody screening therefore helps identify antibodies that may require additional monitoring.
In transfusion medicine, antibody screening helps identify unexpected red-cell antibodies that could react with donor blood.
A positive Indirect Coombs result does not by itself identify the specific antibody.
Further antibody identification and compatibility testing may be required to determine its clinical significance.
Some detected antibodies are clinically important, while others have little or no effect on red-cell survival.
The result therefore needs interpretation within the pregnancy, transfusion or haematology context in which the test was requested.
What Does the Indirect Coombs Test Check?
The test looks for circulating antibodies capable of binding to red blood cells and is particularly relevant to antenatal antibody screening and transfusion compatibility. This test measures 1 biomarker.
Indirect Coombs Test
Detects circulating antibodies in serum that may react against red blood-cell antigens, supporting pregnancy, transfusion and immunohaematology assessment.
Who May Benefit From the Indirect Coombs Test?
Indirect Coombs testing is primarily useful where circulating red-cell antibodies could affect pregnancy or blood transfusion safety.
Pregnant women undergoing red-cell antibody screening - Maternal antibodies can occasionally affect fetal or neonatal red blood cells.
Women with an Rh-negative blood group - Antibody screening forms an important part of antenatal blood-group management.
People preparing for a blood transfusion - Unexpected antibodies can affect donor-blood compatibility.
People with a history of previous transfusions - Exposure to foreign red-cell antigens can lead to antibody formation.
People with a history of pregnancy-related red-cell antibodies - Repeat assessment may be required in subsequent pregnancies.
People with a previous transfusion reaction - Antibody testing can contribute to investigation and future compatibility planning.
People with an unexplained positive antibody screen - Further assessment may help identify the responsible red-cell antibody.
People undergoing specialist immunohaematology assessment - IAT forms part of several red-cell antibody investigations.
How to Prepare
Do not assume that a previous negative antibody screen guarantees that antibodies cannot develop later.
Antenatal and transfusion testing should follow the schedule recommended by the healthcare team responsible for care.
Symptoms and Reasons to Consider the Indirect Coombs Test
The Indirect Coombs test is often performed because of pregnancy or transfusion requirements rather than because the patient has symptoms.
Pregnancy requiring routine antibody screening - Clinically important maternal red-cell antibodies may be present without symptoms.
A previous pregnancy affected by red-cell antibodies - Repeat monitoring may be required.
A history of blood transfusion - Previous exposure can lead to development of unexpected antibodies.
A previous transfusion reaction - Investigation may include antibody screening and identification.
Unexpected anaemia following transfusion - Delayed haemolytic reactions can sometimes be antibody-mediated.
Jaundice or evidence of haemolysis after transfusion - Further immunohaematology investigation may be required.
A known red-cell antibody requiring repeat assessment - Follow-up may help guide pregnancy or transfusion management.
A positive Indirect Coombs test does not necessarily mean active haemolysis is occurring.
Severe transfusion reactions, rapidly falling Haemoglobin, jaundice, breathlessness, chest pain, fever or other acute symptoms following a transfusion require urgent medical assessment.
How to Book Your Indirect Coombs Test
The Indirect Coombs test can be booked privately for circulating red-cell antibody assessment in pregnancy, transfusion or specialist haematology settings.
Choose the Indirect Coombs
Select the individual Indirect Coombs blood test online.
Select your sample collection option
Choose an in-clinic appointment or professional home or hotel phlebotomy where suitable.
Attend your appointment
A trained healthcare professional collects the required venous blood sample and relevant pregnancy or transfusion history should be provided.
Laboratory analysis
Your serum is tested for circulating antibodies capable of reacting with red-cell antigens.
Receive your results securely
Your authorised result is delivered securely and can be reviewed with the appropriate maternity, transfusion or haematology team.
When Will I Receive My Results?
The current expected turnaround for the Indirect Coombs test is approximately 3–4 days after your sample reaches the laboratory.
The laboratory performs red-cell antibody screening using established immunohaematology methods.
The result undergoes analytical review, quality control and authorisation before being released.
Turnaround begins once the specimen reaches the laboratory rather than necessarily on the day of collection.
If the screen is positive, additional antibody identification or compatibility investigations may be required and can take longer than the initial screening turnaround.
Understanding Your Results
A negative Indirect Coombs result means clinically detectable circulating red-cell antibodies were not identified by the screening method at that time.
A positive result means one or more circulating antibodies capable of reacting with red-cell antigens have been detected.
A positive screen does not automatically identify the antibody or determine whether it is clinically significant.
Further testing may therefore be required to establish the antibody specificity.
In pregnancy, the significance depends on the antibody involved, concentration or titre where relevant, fetal antigen status and obstetric history.
In transfusion medicine, identification of the antibody helps the laboratory select compatible donor blood.
The result should therefore be interpreted within the reason for testing rather than treated as a simple positive-or-negative disease diagnosis.
Why Book With London Blood Tests?
London Blood Tests provides private access to specialist red-cell antibody screening for pregnancy, transfusion and haematological assessment.
Detects circulating red-cell antibodies - Identifies antibodies before they bind to target red cells.
Relevant to pregnancy - Can support antenatal antibody screening and assessment of maternal red-cell antibodies.
Important for transfusion safety - Unexpected antibodies can affect donor-blood compatibility.
Different from Direct Coombs testing - Answers a separate immunohaematological question.
Specialist laboratory analysis - Samples undergo professional antibody-screen testing.
Private phlebotomy options - Clinic and suitable mobile blood collection can be arranged.
Secure reporting - Receive your authorised result confidentially.
Clear pricing - The Indirect Coombs test costs £109.
Private Indirect Coombs Blood Test in London
London Blood Tests provides private Indirect Coombs testing in London for people requiring assessment of circulating red-cell antibodies.
The test costs £109 and measures 1 biomarker: Indirect Coombs Test.
Results are expected approximately 3–4 days after laboratory receipt.
Positive screening results may require additional antibody-identification testing to establish their clinical significance.